This meta- analysis concludes that l-arginine supplementation can significantly reduce blood TAG levels ; however , there is insufficient evidence to support its hypocholesterolaemic effects .
A number of clinical trials have examined the effect of l-arginine on lipid profile in recent years ; however , the results remain equivocal .
Therefore , the present study aims to summarise and quantitatively examine the available evidence on the effectiveness l-arginine supplementation on lipid parameters using a systematic review and meta-analytic approach .
Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial
Background : Recently , the potential of L-arginine supplementation as a novel and effective strategy for weight loss and improving biochemical parameters in obese patients has been under consideration . Objectives : To evaluate the influence of 8-week oral L-arginine supplementation on body mass index ( BMI ) , waist circumference ( WC ) , triceps skinfold ( TS ) , subscapular skinfold ( SS ) , systolic blood pressure ( SBP ) , diastolic blood pressure ( DBP ) , plasma fasting blood sugar ( FBS ) , glycated hemoglobin ( HbA1c ) , triglyceride ( TG ) , total cholesterol ( TC ) , low-density lipoprotein ( LDL ) , high-density lipoprotein ( HDL ) , and malondialdehyde ( MDA ) in patients with BMI values > 29.9 or visceral obesity ( WC > 102 cm in men or > 88 cm in women ) . Patients and Methods : Ninety obese patients were included in a single-blind r and omized controlled trial . Patients were r and omized to receive either L-arginine ( 3 or 6 g thrice daily ) or placebo for 8 weeks . Anthropometric and biochemical indices , dietary intake , and blood pressure values were measured at the baseline and after the 8-week intervention . Results : Significant decreases in anthropometric parameters , blood pressure ( SBP , DBP ) , FBS , HbA1c , LDL , MDA ( P < 0.001 ) , TG ( P = 0.02 ) , and TC ( P = 0.002 ) and a significant increase in HDL ( P < 0.001 ) were observed in the intervention group , compared to the control group . In the control group , no significant differences were found between the baseline and end-of-intervention measurements . Conclusions : In conclusion , oral L-Arginine supplementation appears to improve anthropometric parameters , blood pressure values , and some blood biochemical indices associated with cardiovascular disease prevention
This meta- analysis concludes that l-arginine supplementation can significantly reduce blood TAG levels ; however , there is insufficient evidence to support its hypocholesterolaemic effects .
A number of clinical trials have examined the effect of l-arginine on lipid profile in recent years ; however , the results remain equivocal .
Therefore , the present study aims to summarise and quantitatively examine the available evidence on the effectiveness l-arginine supplementation on lipid parameters using a systematic review and meta-analytic approach .